The Prevalence of Skin Diseases in Greece, Impact on Quality of Life and Stigmatization: A Population-Based Survey Study

This study found that 43.35% of the adult population across 27 European countries reported having a skin condition in the past year, highlighting the need for dermatological care planning.

This observational study found that patients with various skin diseases across 17 European countries experience higher levels of perceived stigmatization than skin-healthy controls, particularly those with psoriasis, atopic dermatitis, alopecia, and bullous disorders, with factors such as disease severity and psychological distress influencing stigmatization levels.

This study found that patients with alopecia areata reported worse quality of life and higher anxiety and depression levels compared to those with androgenetic alopecia and healthy controls.

In this study, researchers found that acne, melasma, vitiligo, and atopic dermatitis significantly impact anxiety, depression, loneliness, and quality of life, while alopecia does not have a significant effect.

This chapter reviews advancements in nanocarriers for delivering antipsoriatic drugs to improve skin targeting and therapeutic efficacy, reporting no new experimental results.